The National Cancer Institute (NCI) and National Institute of Biomedical Imaging and Bioengineering (NIBIB) are offering a grant to develop cancer detection, diagnosis, and treatment technologies for low- and middle-income countries. This grant supports the adaptation and validation of user-friendly, low-cost devices or assays that are comparable to current technologies. The funding is provided through the UH2/UH3 phased innovation cooperative agreement award mechanism, requiring multidisciplinary expertise in engineering, oncology, healthcare delivery, and business development. Projects must demonstrate technical functionality and clinical potential in LMIC settings. Applicants must address both UH2 exploratory and UH3 validation phases. Deadline for submission is March 06, 2015.
Opportunity ID: 269791
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-15-001 |
| Funding Opportunity Title: | Cancer Detection, Diagnosis, and Treatment Technologies for Global Health (UH2/UH3) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | 6 |
| Assistance Listings: | 93.286 — Discovery and Applied Research for Technological Innovations to Improve Human Health |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Nov 24, 2014 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Mar 06, 2015 |
| Current Closing Date for Applications: | Mar 06, 2015 |
| Archive Date: | Apr 06, 2015 |
| Estimated Total Program Funding: | $3,000,000 |
| Award Ceiling: | $1,000,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Native American tribal organizations (other than Federally recognized tribal governments) Public and State controlled institutions of higher education Small businesses City or township governments Special district governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education State governments For profit organizations other than small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities County governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) is an initiative to support the development of cancer-relevant technologies suitable for use in low- and middle-income countries (LMICs). Specifically, the FOA solicits applications for projects to adapt, apply, and validate existing or emerging technologies into a new generation of user-friendly, low-cost devices or assays that are clinically comparable to currently used technologies for imaging, in vitro detection/diagnosis, prevention or treatment of cancers in humans living in LMICs.
Funds will be made available through the UH2/UH3 phased innovation cooperative agreement award mechanism. Applicants should have a working assay or prototype (not necessarily already capable of cancer applications). The initial UH2 exploratory phase will be a feasibility study to demonstrate technical functionality and clinical potential for use in LMIC settings by meeting specific performance milestones. UH2 projects that have met their milestones will be administratively considered by NCI and NIBIB and subsequently prioritized for transition to the UH3 validation phase. UH3 awards will support improvements and validations of the technologies in the LMIC settings. Projects proposed in response to this FOA will require multidisciplinary efforts to succeed and therefore all applicant teams must include expertise in engineering/assay/treatment development, oncology, global healthcare delivery, and business development. Investigators responding to this FOA must address both UH2 and UH3 phases. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-15-001.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-C | FORMS-C | PKG00210085 | Feb 06, 2015 | Mar 06, 2015 | View |
Package 1
Mandatory forms
269791 RR_SF424_2_0-2.0.pdf
269791 PHS398_ResearchPlan_2_0-2.0.pdf
269791 PHS398_CoverPageSupplement_2_0-2.0.pdf
269791 RR_Budget_1_3-1.3.pdf
269791 RR_KeyPersonExpanded_2_0-2.0.pdf
269791 RR_OtherProjectInfo_1_3-1.3.pdf
269791 PerformanceSite_2_0-2.0.pdf
Optional forms
269791 PlannedReport-1.0.pdf
269791 PHS398_CumulativeInclusionReport-1.0.pdf
269791 RR_SubawardBudget30_1_3-1.3.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
